drug production

03.10.2024 • News • Bioprocessing

Lilly Announces New $4.5 Billion Site

Eli Lilly and Company (Lilly) recently announced a $4.5 billion (€4.07 billion) investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development.

03.08.2012 • News

Fresenius May Lift Outlook Again on Rivals' Shortages

11.06.2012 • News

Fresenius Lifts Outlook again on Rivals' Shortages

Top-Feature

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Evonik Operations GmbH (Hanau)

Biobased Feedstocks as a Roadmap to Defossilization

Virtual Event

CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Eli Lilly and Company